insights_auto
Why is ARGX down 4,09%?
Dive Deeperchevron_right
ARGX:EBR
argenx SE
727,60 €
arrow_downward
-4,09%(-31,00) 1D
16 հոկ, 17:39:35 GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARGX...
Open
759,20 €
High
761,80 €
Low
727,60 €
Mkt. cap
48,36 մլրդ
Avg. vol.
86,90 հզր
Volume
96,25 հզր
P/E ratio
30,95
52-wk high
925,00 €
52-wk low
568,40 €
EPS
23,51 €
Shares outstanding
35,93 մլն
No. of employees
2 հզր
Open
759,20 €
High
761,80 €
Low
727,60 €
Mkt. cap
48,36 մլրդ
Avg. vol.
86,90 հզր
Volume
96,25 հզր
P/E ratio
30,95
52-wk high
925,00 €
52-wk low
568,40 €
EPS
23,51 €
Shares outstanding
35,93 մլն
No. of employees
2 հզր
News stories
From web sources and news partners
ad-hoc-news.de
·
1 օր առաջ
argenx reports trial results: what it means for argenx stock
TipRanks
·
2 օր առաջ
Argenx Stock Stumbles As Trial Failure Haunts Rally
Yahoo Finance
·
2 օր առաջ
Zacks Investment Ideas feature highlights: Cummins, Argenx and PACCAR
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
About argenx SE